Dry age-related macular degeneration
RecruitingStudy on Long-term Safety of JNJ-81201887 for Patients with Geographic Atrophy Due to Age-related Macular Degeneration
Study on Long-term Safety of JNJ-81201887 for Patients with Geographic Atrophy Due to Age-related Macular Degeneration
- Disease:Dry age-related macular degeneration
- Substances:PrednisoneAdeno-Associated Virus Serotype 2 Encoding Soluble Cd59+1
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Prednisone
- Sponsor:Janssen Cilag International







